Staging ::: VER CORREOS
Acceder

Farmas USA

136K respuestas
Farmas USA
86 suscriptores
Farmas USA
Página
2.945 / 17.039
#23553

Re: Farmas USA

esta tarde de tiendas con la famili y flipando con el móvil y clsn.

framus estas tocado por los dioses.

unas dudas, si tienes stop te barren, ¿en el caso de estar en una situación futura, al llegar a las cercanías de resultados fase III, no poner stop si vas hasta la última mano y te la juegas a all in?.

#23555

Re: Farmas USA

lo clavaste, al infierno directa, mira donde la paran hoy 0,666.
suerte.

#23556

Re: Farmas USA

Yo no pongo stops...ademas mi broker no me deja en USA solo en MC con lo que tampoco tengo ese dilema....mi estrategia es siempre buy&hold....las llevo con precio medio d 4....si bajan un 13% pues ya subiran....de eso ya tuvimos muchas sesiones de ejemplo entre Octubre y Noviembre...no es cierto??

S2

#23557

Re: Farmas USA


CLSN: Intraday Drama but All is Status Quo
for HEAT Outcome Soon

from the Roth Analysis Posted

Celsion has seen some intraday drama with a sharp drop in stock price
followed by a significant rebound. We spoke to management indicating that all
is "status quo" and data from the Phase III HEAT study is still expected by the
end of the month.

Celsion saw a precipitous intraday drop (down>30%) today, only to be followed
by a significant rebound. While this trading activity takes us back to the intraday
"bear raid" seen by Dendreon (DNDN-Neutral-$6.65) just ahead of its Phase III
IMPACT data, we believe things are different here. We spoke to management
as well as Nasdaq in assessing today's drama. In short, management has
indicated that all is status quo in finalizing the HEAT data readout and that
nothing has leaked out. Nasdaq has indicated its belief that the intraday drop
was driven primarily by retail and some short interest pressure coming through.
Recall that the stock performance has been strong and sustainable as of late
as investors have been making bets on HEAT. Other feedback we received
from investors was that if it was a leak or institutional selling, the negative
stock pressure would have been sustained. HEAT has been run at 79 sites
in 11 countries and the "clinical quality dashboard" is set to ensure that any
questions regarding patient data are resolved back at the local site prior to
database lockup, data analysis and submission to the DMC.
Impact
We continue to anticipate a potential positive outcome for the HEAT study
which could be potentially followed by extensive presentation in a peer
reviewed forum (medical meeting/scientific journal). We expect a PFS readout,
as well as topline view on survival trends. Recall that the HEAT study is
conducted under SPA, supporting FDA guidance that ThermoDox is eligible
for approval based on successfully achieving the PFS endpoint. Furthermore,
HEAT is powered to show statistically significant OS improvement, and a
potential OS benefit may enhance the company's pricing power.
Action
We maintain our Buy rating and $10 price target. We believe our valuation to be
considered conservative based on two key factors; 1) conservative projections
for ThermoDox in HCC 2) ThermoDox is in Phase II studie.

#23558

Re: Farmas USA

Es de locos, eh?
Si lo que pone aqui es cierto, que salvaje ha sido.
Se negociaba un paquete 1$ arriba y el siguiente 1$ abajo ... muy burro, no?
http://www.nasdaq.com/symbol/clsn/time-sales?time=9&pageno=97


CLSN

Y aqui es donde sucede la magia y el tiempo desaparece durante 5 minutos, reapareciendo con un bloque bien majo de 300.000 shares. Eso es comprar en los dips , si señor!

#23559

Re: Farmas USA

vamos, no duermes framus, ahora se por que no te cazan, estas más al loro que el cuidador de clsn. no le pierdes el ojo ni un segundo.

buenas noches.

#23560

Re: Farmas USA

Buenos días!!

Framus, estoy leyendo tu estrategia y creo que en nombre del todo el foro tenemos que bautizarla de alguna manera. :-D :-D ¿qué tal la "Framusada"? :-D

Ya lo estoy viendo.... Framusada por aquí, framusada por allí.... ponme una framusada....

Esto se llama "robar las acciones", y ¿quién las roba? pues los propios Market Makers (creadores de mercado) porque si nadie vende, ellos no hacen su negocio. Lo siento por los que les saltaron los stops.

En fin, yo creo que lo que dice Kiyosaki (https://www.rankia.com/foros/bolsa/temas/1081914-farmas-usa?page=2944#respuesta_1637322) con el gráfico de Arna es lo que ha pasado.

Voy a investigar a ver si encuentro alguna otra cosa.